Patent ID: 7371388

Claim:
A method of treating an autoimmune disease or condition associated with an autoimmune disease, comprising administering to a patient an effective amount of an isolated polypeptide comprising a first amino acid sequence at least 90% identical to a second amino acid sequence selected from the group consisting of: (a) a second polypeptide comprising amino acids 4 to 44 of SEQ ID NO:2; (b) a second polypeptide comprising amino acids 4 to 52 of SEQ ID NO:2; (c) a second polypeptide comprising amino acids 4 to 54 of SEQ ID NO:2; (d) a second polypeptide comprising amino acids 8 to 41 of SEQ ID NO:2; (e) a second polypeptide comprising amino acids 1 to 54 of SEQ ID NO:2; and (f) a second polypeptide comprising the extracellular domain of the TR18 receptor polypeptide of SEQ ID NO:2; wherein the autoimmune disease or condition associated with an autoimmune disease is selected from the group consisting of: (i) Sjogren's Syndrome; and (ii) asthma.